Wuhan coronavirus 2019 RdRP gene control


EVAg

Produced by
: CUB
Shipping From
: Berlin - DE

Product Description

Ref-SKU:
003N-03901
In vitro transcribed RNA for Wuhan coronavirus (2019-nCoV) real time (RT-)PCR targeting region of the RdRP gene . Protocol and preliminary evaluation for this assays (Corman/Drosten 2020), as of Jan 13, 2020, available from: https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2 Ref: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045
Product Risk Group: 

Information on the related virus



Unit definition: 
1 x 100 µl

Upon request

218,00 €
(Cost per access for Academics)

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Cloned Product: No
Can it be used to produce GMO: 
No
Sequencing: 
Fully sequenced
Sequence checked: 
Yes
Mutations: 
No mutation compared to the reference sequence
Genbank reference: 
Identification technique: 
PCR
Nucleic Acid preparation technique: 
Cloning of target region followed by T7-driven in vitro transcription using MEGAscript (Asuragen, Lifetech). RNA was subsequently purified by QIAGEN RNeasy kit.
Titer: 
1e5 copies / µl
Storage conditions: 
Nuclease-Free Water -80C
Shipping conditions: 
IATA Classification: 
Virus host type: 
Note: 

Protocol and preliminary evaluation for this assays (Corman/Drosten 2020), as of Jan 13, 2020, available from https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045

Information about the origin of the product

Biological material origin: 
Synthetic origin
Modifications from the reference sequence(s): 
The sequence(s) of this synthetic product has NOT been modified from the sequence listing provided as Genbank references